-David M Spencer Researcher Activity Profile

Research Author Detailed Information 

David M Spencer Publication Rate By Year

David M Spencer has published 11 paper(s) in 2007, 2 paper(s) in 2008, for a total of 13 research publications in total.

David M Dm Spencer Author Information

LAST NAME: spencer

FIRST NAME: David M

INITIALS: dm

AFFILIATION:

Papers

David M Spencer's Publication Record

1. Double-inducible gene activation system for caspase 3 and 9 in epidermis. Year Published: 2007
Center for Molecular Development and Disease, Texas A and M University Health Science Center, Institute of Biosciences and Technology, Houston, Texas 77030, USA.
2. Angiogenesis blockade as a new therapeutic approach to experimental colitis. Year Published: 2007
Division of Gastroenterology, Istituto Clinico Humanitas, Rozzano, Milan 20089, Italy. sdanese@hotmail.com
3. Conditional activation of FGFR1 in the prostate epithelium induces angiogenesis with concomitant differential regulation of Ang-1 and Ang-2. Year Published: 2007
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
4. Level of endothelial cell apoptosis required for a significant decrease in microvessel density. Year Published: 2007
Angiogenesis Research Laboratory, Department of Restorative Sciences, University of Michigan School of Dentistry, Ann Arbor, MI 48109, USA.
5. Vaccine therapy for prostate cancer. Year Published: 2007
U.S. Oncology Research and the Department of Medicine, Section of Medical Oncology, Baylor College of Medicine, Houston, TX 77598, USA; Scott Department of Urology, Baylor College of Medicine, Houston, TX 77030, USA.
6. Enhanced activation of human dendritic cells by inducible CD40 and Toll-like receptor-4 ligation. Year Published: 2007
Scott Department of Urology, Baylor College of Medicine, Houston, TX 77030, USA.
7. Inducible FGFR-1 Activation Leads to Irreversible Prostate Adenocarcinoma and an Epithelial-to-Mesenchymal Transition. Year Published: 2007
Program in Cell and Molecular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA; Department of Immunology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.
8. Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition. Year Published: 2007
Program in Cell and Molecular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.
9. Vaccine therapy for prostate cancer. Year Published: 2007
U.S. Oncology Research and the Department of Medicine, Section of Medical Oncology, Baylor College of Medicine, Houston, TX 77598, USA. guru.sonpavde@usoncology.com
10. DNA repair in response to anthracycline-DNA adducts: A role for both homologous recombination and nucleotide excision repair. Year Published: 2008
Department of Biochemistry, La Trobe University, Victoria 3086, Australia.
11. Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition. Year Published: 2007
Program in Cell and Molecular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.
12. Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition. Year Published: 2007
Program in Cell and Molecular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.
13. DNA repair in response to anthracycline-DNA adducts: a role for both homologous recombination and nucleotide excision repair. Year Published: 2008
Department of Biochemistry, La Trobe University, Victoria 3086, Australia.